Respiratory Syncytial Virus (RSV)
Respiratory syncytial virus (RSV) is a significant cause of severe respiratory illness in premature babies and children up the the age of five years. Symptoms can range from a mild cold-like illness to bronchiolitis and pneumonia. It can easily be confused with other illnesses, such as influenza.
RSV is highly contagious and is a significant concern in hospital wards with premature babies. Treatment is primarily supportive care.
Now diagnostic testing can be done in 13 minutes or less with the first Molecular Rapid Test to detect RSV.
ID NOW™ is an innovative rapid molecular system to aid in the diagnosis of infectious diseases. Its unique isothermal amplication technology removes the need for thermal cycling or nucleic acid purification steps, meaning faster results and better patient management. Read More - ID NOW™
Alere™ i is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Read More - Alere™ i
Alere™ i RSV provides molecular results in 13 minutes or less on the user-friendly Alere™ i platform. Read More - Alere™ i RSV
Alere BinaxNOW® RSV is an in vitro rapid immunochromatographic assay used to detect respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal (NP) swab specimens from symptomatic patients. Read More - Alere BinaxNOW® RSV Card
Clearview® RSV is an in vitro rapid immunoassay intended for the rapid, qualitative detection of respiratory syncytial virus (RSV) directly from nasopharyngeal swab and nasal aspirate specimens in children less than 6 years and adults over the age of 60. Read More - Clearview® RSV
ID NOW™ RSV provides molecular results in 13 minutes or less on the user-friendly ID NOW™ platform. Read More - ID NOW™ RSV